[HTML][HTML] The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell …

G Kchour, SAR Rezaee, R Farid, A Ghantous… - Retrovirology, 2013 - Springer
Background HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an" immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, SA Rezaee, R Farid, A Ghantous… - …, 2013 - search.ebscohost.com
Background: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, SAR Rezaee, R Farid, A Ghantous… - Retrovirology, 2013 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis due to …

[HTML][HTML] The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell …

G Kchour, SAR Rezaee, R Farid, A Ghantous… - …, 2013 - ncbi.nlm.nih.gov
Background HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an" immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, R Rezaee, R Farid, A Ghantous… - …, 2013 - europepmc.org
Background HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an" immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, SA Rezaee, R Farid, A Ghantous… - 2013 - cabidigitallibrary.org
Background: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an" immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, SR Rezaee, R Farid, A Ghantous… - …, 2013 - inserm.hal.science
BACKGROUND: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an" immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, SR Rezaee, R Farid, A Ghantous… - Retrovirology, 2013 - hal.science
BACKGROUND: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

The combination of arsenic, interferon-alpha, and zidovudine restores an" immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia …

G Kchour, R Rezaee, R Farid, A Ghantous… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Background HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …

[PDF][PDF] The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell …

G Kchour, SAR Rezaee, R Farid, A Ghantous… - 2013 - core.ac.uk
Background: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal
prognosis due to chemo-resistance and immuno-compromised micro-environment. The …